[O]
"[O]" is a word and design mark owned by Chan Zuckerberg Initiative, LLC, filed at the USPTO on November 6, 2025. It has been allowed and covers classes 9, 18, 21, 25, 35, 36, 41 and 42.
- Status
- Allowed
- Since July 28, 2026
- Filed
- November 6, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99482783
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 8 classes
Who owns [O]
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Chan Zuckerberg Initiative, LLC
Redwood City, United States
Representative
Anthony Malutta
Kilpatrick Townsend & Stockton LLP
What the mark covers
The products and services [O] is filed for, grouped by Nice class.
Downloadable computer software for use in collecting, organizing, managing, processing, generating, understanding and analyzing data in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; downloadable computer software using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; downloadable computer software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; downloadable computer software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; downloadable software for processing images, graphics and text in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; downloadable computer software for collecting, analyzing and organizing data in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence
Tote bags; Umbrellas
Water bottles sold empty
Clothing for men, women and children, namely, shirts, t-shirts, jackets, tops, and sweat shirts
Promoting technical and scientific investigation, research, and experimentation for others in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; promoting the exchange of information and resources for others within the scientific and medical research community and the technology industry to achieve advances in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; administration and management of research grants; advertising services
Financial services, namely, providing grants and funding research awards for human biology projects, biomedical research projects, biotechnology projects, bioinformatics projects, bioengineering projects, and artificial intelligence projects; funds investment services in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence
Educational services, namely, organizing and conducting conferences, courses of instruction, seminars, and training in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; educational services, namely, arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, multimedia presentations and training in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; providing online computer databases for educational use purposes featuring training information in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; non-downloadable electronic publications, namely, letters, newsletters, articles, news stories being news articles, online journals in the nature of blogs and fact sheets in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence
Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in machine learning model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; research in the field of artificial intelligence (AI) software; research in the field of artificial intelligence technology; design and development of artificial intelligence (AI) software; development and design of computer software; research, development and design of biomedical technologies and new products for others; design of genetic research tools and hardware and software systems for others; developing new technology for others in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; technology services, namely, technological research and development in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; providing facilities for human biology research, biomedical research, biotechnology research, bioinformatics research, bioengineering research, and artificial intelligence research, namely, making laboratories, collaborative work spaces, and computer facilities available for scientific research; providing information about human biology research, biomedical research, biotechnology research, bioinformatics research, bioengineering research, and artificial intelligence research; scientific research; medical research; biomedical research services; biotechnology research; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; research and development services in the field of immunology; research and development in the field of microorganisms and cells; scientific research for medical purposes in the area of infectious, cancerous, and neurodegenerative diseases; research in the field of cell engineering technology; consulting services in the fields of human biology research, biomedical research, biotechnology research, bioinformatics research, bioengineering research, and artificial intelligence research; computer software consulting; consultancy in the field of artificial intelligence (AI) technology; genome sequencing services for scientific and research purposes, namely, DNA analysis services for scientific research purposes; providing genetic sequencing and consulting services for medical research purposes, namely, DNA analysis services for medical research purposes, medical research consulting in the field of genetic sequencing; genetic testing for medical research purposes; medical research involving medical diagnostic testing, monitoring, and reporting, all for medical research purposes
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
- Non-final action e-mailed
6 earlier steps on the official record.
About [O]
Who owns the trademark "[O]"?
The USPTO trademark "[O]" (application 99482783) is owned by Chan Zuckerberg Initiative, LLC.
What is the status of "[O]"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull [O] and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b57-84b1-76ca-a798-02f2789f4476
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b57-84b1-76ca-a798-02f2789f4476",
"object": "trademark",
"mark_text": "[O]",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99482783",
"filing_date": "2025-11-06",
"nice_classes": [
9,
18,
21,
25,
35,
36,
41,
42
],
"owners": [
{
"name": "Chan Zuckerberg Initiative, LLC",
"entity_id": "ent_019ebbba-1034-70b4-9091-94f34cf0b47f"
}
]
}